Twist Bioscience Corporation stock surged 16.1% to close at $184.03 on September 24 — a violent gap-driven repricing from an open of $157.72. The trend is undeniably powerful. Yet overextension risk now sits squarely alongside it.

Key takeaways

• TWST closed at $184.03 on September 24, gaining 16.1% in a gap-driven session from a prior close of $158.50.
• Daily RSI14 hit 74.39 — firmly overbought — while price closed above the upper Bollinger Band at $177.20.
• The Lilly TuneLab partnership, announced September 16, provides the fundamental catalyst behind the rally.
• All three timeframes show bullish EMA stacking but also RSI overbought readings on the daily, hourly,…